中泰证券股份有限公司 关于江苏润普食品科技股份有限公司 2020年员工持股计划第一个锁定期届满事项的核查意见 中泰证券股份有限公司（以下简称"中泰证券"或"保荐机构"）作为江苏 润普食品科技股份有限公司（以下简称"润普食品"或"公司"）向不特定合格 投资者公开发行股票并在北京证券交易所上市的保荐机构，对润普食品履行持 续督导义务，根据《北京证券交易所股票上市规则（试行）》（以下简称"《北交 所股票上市规则》"）《北京证券交易所上市公司持续监管指引第 3 号——股权 激励和员工持股计划》等规范性文件及《江苏润普食品科技股份有限公司公司 章程》《江苏润普食品科技股份有限公司 2020 年员工持股计划》（以下简称 "《员工持股计划》）"的有关规定，对润普食品 2020 年员工持股计划（以下简 称"员工持股计划""本员工持股计划"）第一个锁定期届满事项进行了核查， 并出具如下意见： 一、员工持股计划已履行的相关审批程序 1、2020 年 10 月 12 日，公司召开第二届董事会第十四次会议，审议《江苏 润普食品科技股份有限公司 2020 年员工持股计划（草案）》《江苏润普食品科 技股份有限公司 2020 年员工持股计 ...

Financial Performance - The company's operating revenue for the reporting period was CNY 517.48 million, a decrease of 20.12% compared to the previous year[3] - Net profit attributable to shareholders was CNY 10.77 million, down 85.37% year-on-year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 9.24 million, a decline of 87.66% compared to the previous year[3] - Basic earnings per share were CNY 0.13, representing a decrease of 87.96% year-on-year[3] Assets and Equity - Total assets at the end of the reporting period were CNY 521.22 million, an increase of 8.57% from the beginning of the period[3] - Shareholders' equity attributable to the company was CNY 426.89 million, up 47.44% year-on-year[3] - The company's share capital increased to CNY 88.48 million, a growth of 29.76% compared to the previous year[3] Factors Affecting Performance - The increase in revenue and net profit decline was primarily due to economic downturns, increased market competition, and higher R&D and sales expenses[5] - The company increased its investment in the development of sorbic acid projects, contributing to higher R&D expenses during the reporting period[5] - The company issued new shares, which positively impacted total assets and equity figures[6]

Financial Performance - The company's net profit attributable to shareholders for the reporting period is expected to be 10.77 million yuan, a decrease of 85.37% compared to 73.57 million yuan in the same period last year[2]. - The decline in performance is attributed to economic downturns leading to accelerated destocking in the industry, resulting in weakened short-term demand and increased market competition[3]. Research and Development - The company increased its R&D investment in the sorbic acid project, leading to higher R&D expenses during the reporting period[3]. Selling and Marketing Expenses - Participation in domestic and international exhibitions resulted in increased selling expenses for the company during the reporting period[3]. Inventory Management - The company significantly increased the provision for inventory impairment due to indications of impairment in inventory at the end of the reporting period[3].

证券代码：836422 证券简称：润普食品 公告编号：2023-116 江苏润普食品科技股份有限公司 关于公司使用部分闲置募集资金委托理财进展的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 授权委托理财情况 1、审议情况：2023 年 4 月 26 日，公司第三届董事会第十五次会议及第三 届监事会第十三次会议，审议通过了《关于使用闲置募集资金购买理财产品的议 案》，同意公司自 2023 年 4 月 26 日起 12 个月内，使用总额度不超过人民币 6,000 万元的闲置募集资金进行现金管理购买理财产品，在上述额度内，资金可循环滚 动使用，具体议案内容详见公司在北京证券交易所披露平台（www.bse.cn）披露 的《使用部分闲置募集资金购买理财产品的公告》（公告编号：2023-052）。 2、披露标准：根据《北京证券交易所股票上市规则（试行）》中相关规定， 交易的成交金额占上市公司最近一期经审计净资产的 10%以上且超过 1000 万元 的应当予以披露；上市公司连续 12 个月滚动发生理财的 ...

证券代码：836422 证券简称：润普食品 公告编号：2023-116 江苏润普食品科技股份有限公司 关于公司使用部分闲置募集资金委托理财进展的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 授权委托理财情况 1、审议情况：2023 年 4 月 26 日，公司第三届董事会第十五次会议及第三 届监事会第十三次会议，审议通过了《关于使用闲置募集资金购买理财产品的议 案》，同意公司自 2023 年 4 月 26 日起 12 个月内，使用总额度不超过人民币 6,000 万元的闲置募集资金进行现金管理购买理财产品，在上述额度内，资金可循环滚 动使用，具体议案内容详见公司在北京证券交易所披露平台（www.bse.cn）披露 的《使用部分闲置募集资金购买理财产品的公告》（公告编号：2023-052）。 2、披露标准：根据《北京证券交易所股票上市规则（试行）》中相关规定， 交易的成交金额占上市公司最近一期经审计净资产的 10%以上且超过 1000 万元 的应当予以披露；上市公司连续 12 个月滚动发生理财的 ...

证券代码：836422 证券简称：润普食品 公告编号：2023-113 江苏润普食品科技股份有限公司 第三届监事会第十七次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 10 月 30 日 2.会议召开地点：公司会议室 3.会议召开方式：现场 4.发出监事会会议通知的时间和方式：2023 年 10 月 20 日以通讯方式发出 5.会议主持人：监事会主席李树军 6.召开情况合法、合规、合章程性说明： 本次会议的召集、召开、议案审议程序符合法律、行政法规、部门规章和《公 司章程》的规定。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 （一）审议通过《关于公司 2023 年第三季度报告的议案》 1.议案内容： 根据《北京证券交易所股票上市规则（试行）》（以下简称"《北交所股票上 市规则》"）、《江苏润普食品科技股份有限公司信息披露管理制度》等相关规定和 北京证券交易所《关于做 ...

证券代码：836422 证券简称：润普食品 公告编号：2023-112 江苏润普食品科技股份有限公司 第三届董事会第十九次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 2.会议召开地点：公司会议室 3.会议召开方式：现场与通讯 4.发出董事会会议通知的时间和方式：2023 年 10 月 20 日以通讯方式发出 5.会议主持人：董事长潘如龙 6.开情况合法、合规、合章程性说明： 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 10 月 30 日 本次会议的召集、召开、议案审议程序符合法律、行政法规、部门规章和《公 司章程》的规定。 （二）会议出席情况 会议应出席董事 8 人，出席和授权出席董事 8 人。 董事聂诗军、肖侠、赵耀华、彭中杰因工作原因以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于公司 2023 年第三季度报告的议案》 1.议案内容： 根据《北京证券交易所股票上市规则（试行）》（以下简称"《北交所股票上 市规则》"）、《江苏润普食品科技股 ...

证券代码：836422 证券简称：润普食品 公告编号：2023-115 江苏润普食品科技股份有限公司 二、会议审议和表决情况 公司于 2023 年 10 月 30 日召开第三届董事会第十九次会议，审议通过了《关 于公司拟向中国银行连云港海州支行申请不超过人民币 5000 万元综合授信的议 案》、《关于公司拟向招商银行股份有限公司连云港分行申请不超过人民币 2000 万元综合授信的议案》，上述议案表决情况：同意 8 票，反对 0 票，弃权 0 票。 回避表决情况：议案无需回避表决。上述议案无需提交股东大会审议。 三、本次申请授信额度的必要性及对公司影响 关于拟向银行申请综合授信的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、综合授信基本情况 为满足生产经营及业务发展需要，江苏润普食品科技股份有限公司（以下简 称"公司"）拟向银行申请不超过人民币 7000 万元的综合授信额度。其中拟向 中国银行连云港海州支行申请不超过人民币 5000 万元综合授信、拟向招商银行 股份有限公司连云港分行申请不超过 ...

证券代码：836422 证券简称：润普食品 公告编号：2023-112 3.会议召开方式：现场与通讯 江苏润普食品科技股份有限公司 第三届董事会第十九次会议决议公告 4.发出董事会会议通知的时间和方式：2023 年 10 月 20 日以通讯方式发出 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 5.会议主持人：董事长潘如龙 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 10 月 30 日 2.会议召开地点：公司会议室 本次会议的召集、召开、议案审议程序符合法律、行政法规、部门规章和《公 司章程》的规定。 （二）会议出席情况 会议应出席董事 8 人，出席和授权出席董事 8 人。 董事聂诗军、肖侠、赵耀华、彭中杰因工作原因以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于公司 2023 年第三季度报告的议案》 1.议案内容： 根据《北京证券交易所股票上市规则（试行）》（以下简称"《北交所股票上 市规则》"）、《江苏润普食品科技股份有限公司信息披露管理制度》等相关规定 ...

Financial Performance - The company's operating revenue for the first nine months of 2023 was CNY 391,563,628.37, a decrease of 20.21% compared to CNY 490,743,079.33 in the same period last year[10]. - The net profit attributable to shareholders for the first nine months of 2023 was CNY 16,609,125.61, down 72.31% from CNY 59,989,005.57 year-on-year[10]. - The basic earnings per share for the first nine months decreased by 77.27%, from CNY 0.88 to CNY 0.20[10]. - Total operating revenue for the first nine months of 2023 was CNY 391,563,628.37, a decrease from CNY 490,743,079.33 in the same period of 2022, representing a decline of approximately 20.2%[37]. - Net profit for the first nine months of 2023 was CNY 16,609,125.61, significantly lower than CNY 59,989,005.57 in 2022, reflecting a decrease of approximately 72.3%[39]. - Basic and diluted earnings per share for the first nine months of 2023 were CNY 0.20, down from CNY 0.88 in the same period of 2022, a decline of about 77.3%[39]. Assets and Liabilities - The total assets as of September 30, 2023, increased by 12.17% to CNY 538,523,599.16 from CNY 480,083,218.48 at the end of 2022[11]. - The net assets attributable to shareholders rose by 49.37% to CNY 432,476,689.40 compared to CNY 289,536,521.53 at the end of 2022[11]. - Total liabilities decreased to CNY 106,046,909.76 from CNY 190,546,696.95, a reduction of approximately 44.2%[31]. - The company's total liabilities as of the reporting date were CNY 70,939,193.06, compared to CNY 142,151,711.81 in the previous year, showing a decrease of approximately 50%[35]. - The company's total assets amounted to CNY 471,396,128.01, compared to CNY 407,486,842.29 in the previous year, reflecting an increase of approximately 15.6%[35]. Cash Flow - The cash flow from operating activities for the first nine months was CNY 29,525,279.98, a decline of 56.45% from CNY 67,795,629.84 in the previous year[10]. - Operating cash inflow for the first nine months of 2023 was CNY 493,784,267.40, a decrease of 29.0% compared to CNY 695,871,679.73 in the same period of 2022[43]. - Net cash flow from operating activities for the first nine months of 2023 was CNY 29,525,279.98, down 56.5% from CNY 67,795,629.84 in 2022[44]. - Total cash and cash equivalents at the end of September 2023 reached CNY 101,589,888.40, an increase from CNY 59,346,461.11 at the end of 2022[44]. - Cash inflow from financing activities in the first nine months of 2023 was CNY 161,662,226.82, significantly higher than CNY 50,711,429.06 in the same period of 2022[44]. - Net cash flow from investing activities was negative CNY 83,762,801.59 in 2023, compared to negative CNY 24,354,202.64 in 2022, indicating increased investment outflows[44]. Expenses - The company reported a 34.97% increase in selling expenses, totaling CNY 9,849,485.73, primarily due to higher business hospitality and exhibition costs[12]. - Research and development expenses increased by 37.05% to CNY 11,583,958.02, mainly due to increased raw material usage for sorbic acid research[12]. - Total operating costs for the first nine months of 2023 were CNY 373,716,219.15, down from CNY 417,645,975.99 in 2022, indicating a reduction of about 10.5%[37]. - Research and development expenses for the first nine months of 2023 were CNY 11,583,958.02, up from CNY 8,452,158.86 in 2022, indicating an increase of approximately 37.5%[38]. - The company reported a financial expense reduction, with interest expenses decreasing from CNY 2,627,030.24 in 2022 to CNY 811,217.40 in 2023, a decline of about 69%[38]. Shareholder Information - The total number of unrestricted shares increased from 28,394,210 to 30,594,210, representing 34.58% of total shares by the end of the period[17]. - The total number of restricted shares decreased from 60,088,500 to 57,888,500, accounting for 65.42% of total shares by the end of the period[17]. - The total share capital remained unchanged at 88,482,710 shares[17]. - The number of shareholders holding common stock is 4,438[17]. - The largest shareholder, Pan Rulong, holds 19,180,000 shares, representing 21.68% of total shares[19]. - The second-largest shareholder, Xiong Xinguo, holds 10,500,000 shares, accounting for 11.87% of total shares[19]. - The total shares held by the top ten shareholders amount to 67,481,117, which is 76.27% of total shares[19]. - The company has implemented an employee stock ownership plan, issuing 2,708,500 shares at a price of 2 yuan per share[24]. Legal and Other Matters - There are no significant legal disputes or external guarantees reported during the period[23]. - The company has pledged assets totaling 29,996,776.53 yuan, which is 5.57% of total assets[26]. Inventory and Construction - Inventory decreased to CNY 55,648,668.55 from CNY 72,322,835.62, a decline of about 23.0%[29]. - The company has ongoing construction projects with capitalized costs of CNY 30,295,121.97, up from CNY 25,366,351.39, indicating a growth of approximately 19.1%[30]. - Deferred tax assets decreased to CNY 1,107,799.27 from CNY 1,415,031.49, a decline of about 21.7%[30]. - Short-term borrowings significantly decreased to CNY 970,964.00 from CNY 38,814,375.00, a drop of approximately 97.5%[30]. - The company reported a decrease in accounts receivable to CNY 50,759,395.20 from CNY 48,291,152.53, an increase of about 5.1%[29]. Future Outlook - The company plans to continue focusing on market expansion and new product development to drive future growth[36]. - The company plans to continue focusing on investment activities, as indicated by the significant cash outflows for investments in the first nine months of 2023[44].